Cipla
Patrick O. is an experienced Quality Control (QC) Chemist with a comprehensive background in analytical testing and formulation support across multiple companies. Currently at Cipla as a QC Chemist III since December 2021, Patrick conducts a range of tests including HPLC assays and advanced critical testing. Experience spans from roles at Biotech as a QC Chemist II to earlier positions including formulation assistance at Agensys, quality assurance at Bio-Rad Laboratories, and various QC roles in prominent organizations such as Pfizer and Bachem. Patrick holds a degree in Biological Science with a focus on Molecular Cell Biology and Genetics from the University of Maryland.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.